Search

Thomas J Yellig

from Gobles, MI
Age ~70

Thomas Yellig Phones & Addresses

  • 22868 Lake Shore Dr, Gobles, MI 49055 (269) 628-5838
  • 25301 6Th Ave, Gobles, MI 49055 (269) 628-0304 (269) 628-5838
  • Punta Gorda, FL
  • Kalamazoo, MI
  • Evansville, IN

Publications

Us Patents

Parenteral Combination Therapy For Infective Conditions

View page
US Patent:
20030219461, Nov 27, 2003
Filed:
Mar 20, 2003
Appl. No.:
10/393267
Inventors:
Nancy Britten - Portage MI, US
Niki Waldron - Kalamazoo MI, US
Thomas Yellig - Gobles MI, US
Ching-Chiang Su - Kalamazoo MI, US
International Classification:
A61K039/12
A61K038/00
US Classification:
424/204100, 514/002000
Abstract:
A method is provided for treatment or prevention of an infective condition having an inflammatory component. The method comprises parenteral administration of an antibacterial agent in an antibacterially effective amount, in combination therapy with a selective cyclooxygenase-2 inhibitor in an amount sufficient to provide systemic anti-inflammatory activity. Also provided is a parenterally deliverable pharmaceutical composition comprising an antibacterial agent and a selective COX-2 inhibitor together with one or more excipients.

Pharmaceutical Compositions Having A Modified Vehicle

View page
US Patent:
20040170650, Sep 2, 2004
Filed:
Nov 12, 2003
Appl. No.:
10/706255
Inventors:
Ondrej Hendl - Portage MI, US
Susan Machkovech - Mattawan MI, US
Niki Waldron - Kalamazoo MI, US
Nancy Britten - Portage MI, US
Dannette Shaw - Hopkins MI, US
Alanta Lary - Kalamazoo MI, US
Thomas Yellig - Gobles MI, US
International Classification:
A61K039/12
A61K039/02
A61K035/78
US Classification:
424/204100, 424/234100, 424/093400, 424/093600, 424/776000
Abstract:
A composition comprising: (a) one to three bioactive agents; and (b) a vehicle comprising; (i) a modified liquid carrier, and (ii) an unmodified liquid carrier wherein the ratio by volume of the modified liquid carrier to the unmodified liquid carrier is between 0.00001:99.99999 to less than 0.01:99.99, that provide the composition with predictable sustained-release properties and wherein immediately after manufacture of the composition, said composition can be administered to a host such that the one to three bioactive agents is released to the host on a sustained basis.
Thomas J Yellig from Gobles, MI, age ~70 Get Report